Disruptive Drug Discovery
Quiver is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets. Using advanced single cell imaging and multi-omics, we are building the world's most information-rich neuronal insight map "Genomic Positioning System" through state-of-the-art proprietary engineering and AI/ML approaches.
The Challenge
Traditional drug discovery efforts for CNS disorders have significant limitations. The CNS is a uniquely challenging field given the complexity of target tissue, and a translational gap exists where non-clinical models typically fail to reproduce human biology and deliver robust datasets. We have built our platform to traverse this gap.
Our Approach
We integrate powerful enabling technologies along three axes—advanced human biology, determinative measurement engineering, and algorithmic analysis—into a proprietary platform that redefines CNS drug discovery.
Our Vision
Our cutting-edge tools are generating the world's largest and most information-rich map of neuronal biology in both healthy and disease-states to bring forward transformational medicines for the CNS.
Leadership
Team

Adam Barnett, Ph.D.
Data Scientist / Senior Software Engineer
Nate Bremmer
Engineer I

Aishwarya Dhandapani
Associate Scientist

Joe Dwyer
Manager, Lab Operations

Luis Borja
Associate Engineer

Noélle Germain, Ph.D.
Manager, Grants & Scientific Communication

Jennifer Grooms
Research Associate III

Lakshmi Hariharan
Manager, Accounting & Financial Systems

Karthiayani Harikrishnan
Scientist I

Benjamin Harwood, Ph.D.
Principal Scientist

Nina Heath
Senior Research Associate

Jane Jacques
Senior Production Manager

Caitlin Lewarch, Ph.D.
Senior Principal Bioinformatics Scientist

Josh Meier
Senior Research Associate

Aayush Shroff
Research Associate II

Fabricio Simao, Ph.D.
Senior Principal Scientist

Mahdi Torkashvand, Ph.D.
Data Scientist

Eithne Walsh
Research Associate

Jianying Wang
Accountant, Accounts Payable

Dawei Zhang
Scientist II

Aleecia Centeno
Business Operations Manager